Keywords: icn, start, ph, iii, studies, viramidine, pharmaceuticals

ICN to start Ph III studies for Viramidine

Article | 17 November 2003

Print This

ICN Pharmaceuticals has revealed that it is to commence Phase IIIevaluation of its antiviral agent, Viramidine, for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in